APA (7th ed.) Citation

Takeshita, T., Yamamoto, Y., Yamamoto-Ibusuki, M., Tomiguchi, M., Sueta, A., Murakami, K., & Iwase, H. (2018). Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer. Molecular cancer, 17(1), 67-6. https://doi.org/10.1186/s12943-018-0808-y

Chicago Style (17th ed.) Citation

Takeshita, Takashi, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki, Mai Tomiguchi, Aiko Sueta, Keiichi Murakami, and Hirotaka Iwase. "Clinical Significance of Plasma Cell-free DNA Mutations in PIK3CA, AKT1, and ESR1 Gene According to Treatment Lines in ER-positive Breast Cancer." Molecular Cancer 17, no. 1 (2018): 67-6. https://doi.org/10.1186/s12943-018-0808-y.

MLA (9th ed.) Citation

Takeshita, Takashi, et al. "Clinical Significance of Plasma Cell-free DNA Mutations in PIK3CA, AKT1, and ESR1 Gene According to Treatment Lines in ER-positive Breast Cancer." Molecular Cancer, vol. 17, no. 1, 2018, pp. 67-6, https://doi.org/10.1186/s12943-018-0808-y.